Search - tctmd.com

Displaying 101 - 120 of 127

Sort: Relevancy | Date

Presentation TCT 2014

DKCRUSH-VI: A Prospective, Randomized Trial of FFR-Guided Versus Angiography-Guided Provisional T-Stenting in Patients with True Coronary Bifurcation Lesions

Presenter: Gregg W. Stone, Pieter C. Smits, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys

September 14, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

Presentation TCT 2013

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Ian Meredith

October 31, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by NIRS-IVUS (with Case Vignettes): Current Data and PROSPECT II

Presenter: David Erlinge

October 30, 2013

Presentation TCT 2013

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Presenter: Javier Escaned

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

News Conference News TCT 2013

Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children

October 29, 2013

Presentation TCT 2013

ADO-II: A Prospective Registry Study of Patent Ductus Arteriosus Closure Using a Novel Device

Presenter: Daniel Gruenstein

October 28, 2013

News Conference News TCT 2012

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

October 25, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

News Conference News TCT 2012

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

October 23, 2012

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

Advertisement

DKCRUSH-VI: A Prospective, Randomized Trial of FFR-Guided Versus Angiography-Guided Provisional T-Stenting in Patients with True Coronary Bifurcation Lesions

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

COMPARE II: BES, EES Show Similar Outcomes at Three Years

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Second-Generation TAVR Device Overcomes Issues of Current Valves

Vulnerable Plaque Diagnosis by NIRS-IVUS (with Case Vignettes): Current Data and PROSPECT II

ADVISE II: A Prospective, Registry Evaluation of iFR vs. FFR

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Novel Ischemia Measurement Strategies Show Potential vs. FFR

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children

ADO-II: A Prospective Registry Study of Patent Ductus Arteriosus Closure Using a Novel Device

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content